# Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

> **NCT07749924** · NA · RECRUITING · sponsor: **Tianjin Medical University Second Hospital** · enrollment: 670 (estimated)

## Conditions studied

- Bladder Cancer
- Non-Muscle-Invasive Bladder Cancer (NMIBC)

## Interventions

- **OTHER:** Active Surveillance
- **DRUG:** Adjuvant Intravesical Chemotherapy

## Key facts

- **NCT ID:** NCT07749924
- **Lead sponsor:** Tianjin Medical University Second Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-10
- **Primary completion:** 2029-03-01
- **Final completion:** 2032-03-01
- **Target enrollment:** 670 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749924, "Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*